Published in Semin Pediatr Surg on November 01, 1999
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol (1996) 2.69
Do mussels take wooden steps to deep-sea vents? Nature (2000) 2.32
A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther (2014) 1.64
Structural analysis of CTLA-4 function in vivo. J Immunol (2000) 1.61
High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest (1995) 1.33
Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS. Aliment Pharmacol Ther (2012) 1.05
A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. Aliment Pharmacol Ther (2006) 0.97
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast Cancer Res Treat (2011) 0.93
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140. J Clin Oncol (2003) 0.92
Identification of the sites of interaction between c-Raf-1 and Ras-GTP. Oncogene (1995) 0.92
Employment after a breast cancer diagnosis: a qualitative study of ethnically diverse urban women. J Community Health (2012) 0.90
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Ann Oncol (2013) 0.89
An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer. Ann Oncol (2009) 0.87
Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Brain Res Mol Brain Res (1994) 0.85
Long-term growth and development in children after home parental nutrition. J Pediatr (1998) 0.85
Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis. Aliment Pharmacol Ther (2006) 0.84
Gastric retention of zinc-based pennies: radiographic appearance and hazards. Radiology (1999) 0.82
Compact, integrated dynamic holographic memory with refreshed holograms. Opt Lett (1997) 0.78
Variable gene expression within human tyrosinemia type 1 liver may reflect region-specific dysplasia. Hepatology (1996) 0.76
Repair of retinal detachment caused by cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 0.75
Interferon alfa-2a in the treatment of exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (1993) 0.75
Holographic data storage in a DX-center material. Opt Lett (1997) 0.75
Storage of 1000 holograms with use of a dual-wavelength method. Appl Opt (1997) 0.75
Preadmission management of acute gastroenteritis in children. Med J Aust (1991) 0.75
Long-term, successful maintenance of bilateral cytomegalovirus retinitis using exclusively local therapy. Arch Ophthalmol (1996) 0.75
Changes in the ultrastructural localization of mRNA for a circadian regulated protein. Mol Mar Biol Biotechnol (1996) 0.75